Article type
Year
Abstract
Background: Evidence-based medicine (EBM) is one of the fastest growing disciplines in the 21st century. Since it was introduced into China in 1996, it has made great progress. The most important EBM academic conference in China is the Asia-Pacific Conference on EBM, and the 8th conference will be held from 27 to 29 March 2015 in Chongqing city. The accepted abstracts will be directly associated with the research activities of the area.
Objectives: The study aims to survey research activities of EBM in China, and to provide further theoretical basis for the development of EBM in China.
Methods: All accepted abstracts in the 8th Asia-Pacific Conference on EBM were included. Their topic, author, institution and province were all analyzed by SPSS 17.0 software.
Results: A total of 429 abstracts were included. Topic coverage showed that: evidence-based methodology research included 90 abstracts; evidence-based public health and health decision making included 73 abstracts; evidence-based education, patient safety and evidence translation and dissemination included 39 abstracts; evidence-based clinical medicine included 119 abstracts; evidence-based pharmacy and rational drug use included 19 abstracts; evidence-based Traditional Chinese Medicine included 50 abstracts; and guideline evaluation and development included 39 abstracts. Authors were located in 22 provinces (Figure), with Gansu, Chongqing and Sichuan ranking as the top three. The main authors were located in eastern and western China. The provinces providing no abstracts were mainly in the northeast and central China. When these provinces were compared with the location of branch centers of the Chinese EBM Center in China, only Henan province had no abstract (1/15); nine provinces where there is no branch center did not submit an abstract (9/18).
Conclusions: The development of EBM is not balanced within China. The next strategy should be to set up branch centers in central and northeast China, and to promote the development of EBM in China, to perfect China's EBM network.
Objectives: The study aims to survey research activities of EBM in China, and to provide further theoretical basis for the development of EBM in China.
Methods: All accepted abstracts in the 8th Asia-Pacific Conference on EBM were included. Their topic, author, institution and province were all analyzed by SPSS 17.0 software.
Results: A total of 429 abstracts were included. Topic coverage showed that: evidence-based methodology research included 90 abstracts; evidence-based public health and health decision making included 73 abstracts; evidence-based education, patient safety and evidence translation and dissemination included 39 abstracts; evidence-based clinical medicine included 119 abstracts; evidence-based pharmacy and rational drug use included 19 abstracts; evidence-based Traditional Chinese Medicine included 50 abstracts; and guideline evaluation and development included 39 abstracts. Authors were located in 22 provinces (Figure), with Gansu, Chongqing and Sichuan ranking as the top three. The main authors were located in eastern and western China. The provinces providing no abstracts were mainly in the northeast and central China. When these provinces were compared with the location of branch centers of the Chinese EBM Center in China, only Henan province had no abstract (1/15); nine provinces where there is no branch center did not submit an abstract (9/18).
Conclusions: The development of EBM is not balanced within China. The next strategy should be to set up branch centers in central and northeast China, and to promote the development of EBM in China, to perfect China's EBM network.